 Probucol
"Probucol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
| Descriptor ID |
D011341
|
| MeSH Number(s) |
D02.455.426.559.389.657.746
|
| Concept/Terms |
Lurselle- Lurselle
- Aventis Brand of Probucol
- Hoechst Brand of Probucol
|
Below are MeSH descriptors whose meaning is more general than "Probucol".
Below are MeSH descriptors whose meaning is more specific than "Probucol".
This graph shows the total number of publications written about "Probucol" by people in UAMS Profiles by year, and whether "Probucol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 0 | 1 | 1 | | 2009 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Probucol" by people in Profiles over the past ten years.
-
Farahmand F, Malik A, Sharma A, Bagchi AK, Singal PK. Role of oxidative stress versus lipids in monocrotaline-induced pulmonary hypertension and right heart failure. Physiol Rep. 2021 11; 9(22):e15090.
-
Wang H, Zhang K, Ruan Z, Sun D, Zhang H, Lin G, Hu L, Zhao S, Fu Q. Probucol enhances the therapeutic efficiency of mesenchymal stem cells in the treatment of erectile dysfunction in diabetic rats by prolonging their survival time via Nrf2 pathway. Stem Cell Res Ther. 2020 07 21; 11(1):302.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|